The American Diabetes Association issued the following joint statement with 37 other organizations:. U.S., which found all of the Affordable Care Act to be unconstitutional, 38 patient groups issued the following statement:. "In eliminating the ACA penalty for individuals who are not insured, Congress did not intend that individuals could once aga
Swedish biopharma company BioArctic has secured clearance from US Federal Trade Commission to out-licence its alpha-synuclein antibody portfolio to AbbVie. AbbVie decided to licence the therapeutics under an option that is part of the research, development, option and license agreement signed with BioArctic in September 2016. Under the partnership,
President Trump and some congressional Republicans are portraying federal Judge Reed O'Connor's ruling striking down the Affordable Care Act as an opportunity to return to last year's ACA "repeal and replace" proposals, which they argue could solve the problems the ruling would create if allowed to stand. Fortunately, Judge O'Connor's ruling does n
Anaesthesia And Respiratory Devices Market By Device, Respiratory Devices And By Region- Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts. Anaesthesia and Respiratory Devices Market Overview. Anesthetic devices supply an accurate and continuous supply of medical gases associated with a precise concentration of anesthetic vapor a
The University of Wisconsin Madison campus issued the following news:. Activity trackers might lead to better outcomes for hospital patients when nurses wear them. Now a UW-Madison School of Nursing professor is taking them a step further by using them to track nurse movement in hospitals.
Frost and Sullivan, a provider of market research and analysis, growth strategy consulting and corporate training services across multiple industries, issued the following news release:. "Pharmaceutical companies are increasingly recognizing the value of deploying Artificial Intelligence- based platforms that can leverage data regarding gene...
On December 17 Asarina Pharma's Scientific Advisory Board gave its full backing to the company's upcoming trial of a new preventive treatment for Menstrual Migraine. Sepranolone, the new therapy from Asarina Pharma, aims to prevent Menstrual Migraine from occurring. Asarina Pharma's SAB has now given its input and full backing on the proposed proto
Japanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405 m. Astellas made an upfront payment of $164.6 m; Potenza will be eligible for additional payment of up to $240.1 m dependent on the progress of different programmes in clinical development. Following the completion of t
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced that the first patients have been enrolled in two global Phase 3 clinical trials of its investigational anti-PD-1 antibody, tislelizumab.
INGELHEIM AM RHEIN, Germany, Dec. 17 Boehringer Ingelheim, a pharmaceutical company, issued the following news release:. -Boehringer Ingelheim reconfirms its commitment to developing new innovative solutions to address current challenges. Boehringer Ingelheim has developed ASF COMBAT.
CLEARWATER, FL Bovie Medical Corporation, a maker of medical devices and supplies and the developer of J-Plasma , a patented surgical product marketed and sold under the Renuvion Cosmetic Technology brand in the cosmetic surgery market, today announced the appointment of Tara H. Semb as Chief Financial Officer, effective January 2, 2019.
Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea and a tenant company of JLABS@ TMC in Houston, Texas, announced that the Investigational New Drug application for BBT-877, a potent best-in-class drug candidate for Idiopathic Pulmonary Fibrosis, has been cleared by the US Food and Drug Administrati
The FDA has approved Celltrion and Tevas biosimilar of Roches breast cancer drug Herceptin, the second potential competitor to the cancer blockbuster in the US. All three are threatened by biosimilar competition, although Mylan and Celltrion will be unable to launch Herceptin in the US until the patent expires. Celltrion and Teva began an exclusive
Strategic collaboration agreement with Sandoz to develop digital anti-infectives platform Collaboration leverages Ares Genetics antibiotic resistance database ARESdb Short-term focus on repurposing existing antibiotics to treat infections with multi drug resistant pathogens Vienna, Austria, Holzgerlingen, Germany and Amsterdam, The...
Under the terms of the agreement, Innovare will use DelSiTech's technology on its peptide membrane fusion inhibitor, targeting the envelope protein of human immunodeficiency virus-1. "This agreement with Innovare follows an already successful and long-lasting collaboration on this peptide", said Dr. "Using DelSiTech's platform, we have developed
We have a chance, working with the Democrats, to deliver great HealthCare! A confirming Supreme Court Decision will lead to GREAT HealthCare results for Americans! The ruling is expected to spark a heated fight in the court system and on Capitol Hill, where Democrats who rally for the Affordable Care Act, also known as Obamacare, and Medicare for A
Medical device firm EhmetDx has secured 510 clearance from the US Food and Drug Administration for its X-Ray 3 D CBCT positioning software. PhotoElectron is currently PhotoElectron, while Still River Systems is Mevion Medical Systems). Based in Plymouth of Michigan, EhmetDx is formed by a consortium of healthcare-focused engineers, scientists and..
ExCellThera Inc., a biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that the U.S. Food and Drug Administration has granted the ExCellTheras lead solution, ECT-001, orphan drug designation for the prevention of graft-versus-host-disease.
A federal judge in Texas threw a dagger into the Affordable Care Act on Friday night, ruling that the entire health care law is unconstitutional because of a recent change in federal tax law. the president wrote just after 9 p.m. "Now Congress must pass a STRONG law that provides GREAT healthcare and protects pre-existing conditions. For their part
Agency: " Food and Drug Administration, HHS." SUMMARY: The Food and Drug Administration is announcing our intent to consider the appropriate classification of hyaluronic acid intra-articular products intended for the treatment of pain in osteoarthritis of the knee. FOR FURTHER INFORMATION CONTACT: Leigh Hayes, Office of Combination Products, Food a
GC Pharma announced on Dec. 17 it has won approval from the local public health authority to carry out clinical tests on a drug that can be used to treat hemophilia. The drug company, also known as Green Cross, said the Ministry of Food and Drug Safety has granted approval for testing of the MG1113 on people. It marks the first time for a locally m
Glenmark Pharmaceuticals has got approval from the US Food and Drug Administration to launch its generic version of hydrocortisone valerate ointment USP, 0.2%, which is indicated for the treatment of a variety of skin conditions.
New York, NY 12/17/2018 A report on Disposable Medical Gloves begins with a deep introduction of the global Disposable Medical Gloves market and then delves broad into specific segments such as type, material, application, end user, and region, policy study, Disposable Medical Gloves value chain structure, and upcoming trends in particular se
Valley Cottage, NY 12/17/2018 Future Market Insights delivers key insights and presents a revised forecast of the global vital signs monitoring devices market for a 10 year period from 2017 to 2027 in an upcoming report titled "Vital Signs Monitoring Devices Market: Global Industry Analysis and Opportunity Assessment 2017 2027." The global
Sarasota, FL 12/18/2018 Zion Market Research has published a new report titled "Personalized Medicine Market by Therapeutic Area, by Application, by End-User, and by Technology: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 2024". According to the report, the global personalized medicine market was valued at appro